Navigation Links
SynCardia Introduces New 12-lb Freedom Discharge Driver ,Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
Date:4/22/2009

Latest Generation of Driver Technology to Power Artificial Heart Presented at ISHLT in Paris

Tucson, Ariz. (Vocus) April 22, 2009 -- On April 22-25, SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, introduced the new 12-lb Freedom™ discharge driver at the International Society for Heart and Lung Transplantation (ISHLT) meeting in Paris.

The small, light and “wearable” Freedom driver is designed to provide stable SynCardia Total Artificial Heart patients with a quality “lifestyle” outside the hospital while they wait for a matching donor heart. The Freedom driver is designed to allow patients to live at home, spend time with their family and friends, shop, travel, dine out, attend sporting events, vacation and even return to work.

“The Freedom driver is the next generation in pneumatic driver technology for powering the Total Artificial Heart outside the hospital,” said Rodger Ford, CEO and president of SynCardia. “Our experience discharging stable patients in Europe using our CE approved portable driver has demonstrated that Total Artificial Heart patients can enjoy an active lifestyle at home and in their communities.”

Currently in the U.S., stable Total Artificial Heart patients cannot be discharged. These patients – who are otherwise healthy – must spend weeks, often months trapped in the hospital while they wait for a donor heart. Life for a stable Total Artificial Heart patient confined to the hospital is emotionally, physically and financially draining for them, their family and the hospital.

When the Freedom driver is approved for an FDA / Investigational Device Exemption (IDE) clinical study, stable Total Artificial Heart patients will be discharged from the hospital for the first time in the U.S. Discharge improves quality of life whi
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. The ASDS Introduces the First At-Home Skin Cancer Exam Kit
2. AMD LASERS(TM) Introduces the Picasso Diode Laser
3. Amoena Introduces First Post Surgical Garments With Vitamin E & Aloe to Help Soothe and Comfort After Breast Surgery
4. Blue Cross and Blue Shield of Florida Introduces BlueMedicare(SM) Group Supplement
5. Passlogix Introduces Industry's Fastest Sign-On to Kiosks with New Enhancements to v-GO Session Manager
6. Sentillion Introduces Advanced Authentication Solution For Direct Access to Cerner, Eclipsys, Epic, McKesson and MEDITECH Applications
7. Vinpower Digital Introduces Series of Standalone 8X Blu-ray Disc Duplicators with LightScribe Printing Capability
8. Allscripts Introduces SaaS Solution for Prenatal Care
9. Allscripts Introduces Electronic Health Record Capability for iPhone(TM)
10. Covaris Introduces DNA Shearing Service
11. Heavenly Essence Introduces Pureity - the Only Line of Hair Care Products That Really Cares About You

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
SynCardia Introduces New 12-lb Freedom Discharge Driver ,Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
SynCardia Introduces New 12-lb Freedom Discharge Driver ,Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
(Date:11/30/2009)...demic seems to ebb, CDC notes a rise in child deat...HealthDay News) -- U.S. health officials said Mon... the wane nationally, even as the number of Americ...se. , The latest report, released Monday by the...CDC), finds that "visits to doctors for influenza-...
(Date:11/30/2009)..., Sponsored by Merck, the unique online and mob...ts in their HIV treatment decisions ,, ARLINGT...ody ( www.thebody.com ), the #1 HIV/AIDS resource ...e and mobile tool offering HIV/AIDS-infected patie...edical data. The tool, created with sponsorship fr...
(Date:11/30/2009)... , Study Uses Tent To Simulate...K, Nov. 30 Distance run...vels are known to improve their performance during... failure patients, who suffer from fatigue, improv...like, high-altitude simulator? ,, That is the q...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Of the ...who are living with HIV/AIDS, nearly half are Afri...es in Washington, D.C. have surpassed the threshol... women account for more than 90 percent of all wom.... On Tuesday, December 1 at 6:00 p.m.*, World AIDS...
(Date:11/30/2009)... a tiny period of time between the registration of... conscious recognition of it ― between the t...s an apple. Our minds lag behind our eyes, but by ...o the world around us? , Some estimates say th...ay 500 milliseconds. A new study by Tel Aviv Unive...
Breaking Medicine News(10 mins):Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:Now you see it, now you know you see it 2
...(FDA) has approved DORIBAX(TM),(doripenem for inje...dominal and complicated urinary tract infections, ... activity against a wide range of,Gram-positive an...cquire,bacterial infections in hospitals each year...
...es pose big stomach risks, study notes , ...s of patients don,t tell their doctors that they t...spirin and ibuprofen, a potentially dangerous omis...reasing yearly," said study lead author Dr. Raj T....
...tive African-American men could be putting their p... research in the latest UK-based Journal of Advanc...er men in the USA found that many of the 40 to 65 ...ex and 22 per cent having unsafe anal sex. The res...
...ed to contribute to heart attack, stroke and demen... vision loss, researchers say. , Homocysteine lev...blem for Americans whose diets are often poor in f...t to know the impact of resulting elevated homocys...
... More Transplant Patients and Family ...5 The National Foundation for,Transplants (NFT) a...s to,more transplant patients and families in need...is made possible by a sponsorship from,Roche which...
...nual ASRM Meeting, WASHINGTON, Oct. 15 Twelve lu... 2007 My Little Miracle Essay Contest for their,dr...ir ,little miracles,children born with the help of...follitropin for injection, purified),and/or MENOPU...
Other Medicine News:Health News:MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 3Health News:Older African-American men with HIV often have sex without condoms 2Health News:Impact of elevated homocysteine levels on vision under study 2Health News:Impact of elevated homocysteine levels on vision under study 3Health News:National Foundation for Transplants to Expand Program Providing Hotel Accommodations to Patient Families 2Health News:National Foundation for Transplants to Expand Program Providing Hotel Accommodations to Patient Families 3Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 2Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 3Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 4
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Cardiac Defibrillators - A Worldwide Market ...r.com/p0164315/Cardiac-Defibrillators---A-Worldwid...scular disease (CVD) is one of the foremost causes...ors are prone to arrhythmic disorders, calling the...
(Date:11/30/2009)...ire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ ), ...documentation services, today announced that it ha...Inc. (Nuance) under which MedQuist will now licens...nd processing software for use in SpeechQ of Gener...nition application for all medical disciplines. S...
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Diabetes Diagnostics - A Global Market Persp...7/Diabetes-Diagnostics---A-Global-Market-Perspecti...n by a steady increase in the number of people dia...veloping parts of the world, and increase in inten...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Dominion Diagnostics Continues To Lead Through On Demand Laboratory Science 14387 1Dominion Diagnostics Continues To Lead Through On Demand Laboratory Science 14387 2Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 1Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 2Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 3Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 4NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 1NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 2
...Robert Figlin Highlights Phase 2 Data Showing 31%,...enefit Rate to Perifosine, Used as a Single Agent... Toxicity When Combined with Soraf...Inc. today announced positive phase 1 & 2 data of ...nal cell carcinoma (RCC). In an oral presentation,...
...routine screening, WASHINGTON, Nov. 8 Today, Tes... for Public Health and the North,Carolina Rules Re...lude the,Centers for Disease Control and Preventio...rt of routine medical care. Now in North Carolina,...nt and pre-test counseling is,no longer required.,...
Other Medicine Technology:Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 2Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 3Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 4Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 5Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 6Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 7Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing 2
Pediatric Urethral C-Stents
Safety Wire Guide Introducer Set
Movable Core Curved Safe-T-J® Wire Guides
Fixed Core Curved Safe-T-J® Wire Guides - Standard (stainless steel)
Medicine Products: